MiR-21 and Tocilizumab interactions improve COVID-19 myocarditis outcomes
Description
CONCLUSION: Using Tocilizumab in early diagnosed COVID-19 myocarditis patients can save their cardiac function after hospitalization and decrease the mortality rate. miR-21 level determines the outcome and responsiveness of COVID-19 myocarditis to
